Safety of Atrovent® CFC-Free MDI (Metered Dose Inhaler): An Example of Protopathic Bias in Observational Cohort Studies

被引：0
|
作者：
Osborne, Vicki [1 ,2 ]
Layton, Deborah [1 ,2 ]
Tong, Edward [1 ,2 ]
Shakir, Saad A. [1 ,2 ]
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
[2] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
579
引用
收藏
页码：S252 / S253
页数：2
相关论文
共 11 条
  • [1] Safety of Atrovent® CFC-Free MDI (Metered Dose Inhaler): An Example of Protopathic Bias in Observational Cohort Studies
    Osborne, V.
    Layton, D.
    Tong, E.
    Shakir, S.
    DRUG SAFETY, 2011, 34 (10) : 939 - 939
  • [2] Active Surveillance of the Introduction of Atrovent® CFC-Free MDI (Metered Dose Inhaler) into General Practice in England: Characteristics of Users
    Osborne, Vicki
    Layton, Deborah
    Tong, Edward
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S341 - S342
  • [3] Active Surveillance of the Introduction of Atrovent® CFC-free MDI (Metered Dose Inhaler) into General Practice in England: Characteristics of Users
    Osborne, V.
    Layton, D.
    Tong, E.
    Shakir, S.
    DRUG SAFETY, 2011, 34 (10) : 939 - 940
  • [4] Drug utilisation and safety of Atrovent® (Ipratropium) inhaler CFC-Free MDI in children in a cohort of first users in England
    Fogg, C.
    Waller, R.
    Wilton, L.
    Shakir, S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S65 - S65
  • [5] Safety of Atrovent((R)) CFC-free inhaler: respiratory events reported from an observational cohort study in England
    Osborne, Vicki
    Layton, Deborah
    Fogg, Carole
    Tong, Edward
    Shakir, Saad A. W.
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2018, 26 (04) : 356 - 363
  • [6] The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler
    Ganderton, D
    Lewis, D
    Davies, R
    Meakin, B
    Church, T
    RESPIRATORY MEDICINE, 2003, 97 : S4 - S9
  • [7] ACUTE SAFETY OF THE CFC-FREE PROPELLANT HFA-134A FROM A PRESSURIZED METERED-DOSE INHALER
    DONNELL, D
    HARRISON, LI
    WARD, S
    KLINGER, NM
    EKHOLM, BP
    COOPER, KM
    PORIETIS, I
    MCEWEN, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (06) : 473 - 477
  • [8] Awareness of the ozone layer and acceptance of a new CFC-free metered dose inhaler among asthmatic patients
    Liam, CK
    Lim, KH
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (08) : 683 - 689
  • [9] Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone
    Leach, CL
    Davidson, PJ
    Boudreau, RJ
    EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (06) : 1346 - 1353
  • [10] Pharmacokinetics and dose proportionality of beclomethasone from three strengths of a CFC-free beclomethasone dipropionate metered-dose inhaler
    Harrison, LI
    Dahl, DR
    Cline, A
    Chang, SF
    Machacek, J
    Nelson, J
    Kannianinen, C
    Purrington, A
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1997, 18 (07) : 635 - 643
12